**Question:** All are true except-

A. Asthma is a chronic respiratory disease characterized by airway inflammation and narrowing.
B. Bronchodilators are medications that relax smooth muscle in the airways, leading to bronchodilation and improved airflow.
C. Antihistamines are medications that block histamine receptors, reducing histamine-induced responses like allergy symptoms.
D. Corticosteroids are medications that suppress the immune system, reducing inflammation and immune responses.

**Correct Answer:**

A. **Option C (Antihistamines aren't specifically mentioned):** Antihistamines primarily block histamine receptors, reducing histamine-induced responses like allergy symptoms. However, they do not specifically address airway inflammation which is a key feature of asthma.

B. **Option B (Bronchodilators aren't mentioned):** Bronchodilators are medications that relax smooth muscle in the airways, leading to bronchodilation and improved airflow. They are essential in treating asthma symptoms, but they do not address the underlying inflammation that characterizes the condition.

C. **Option C (Bronchodilators aren't mentioned):** As mentioned before, anticholinergics are a subclass of bronchodilators that act as muscarinic antagonists and help relax bronchial smooth muscle, thereby relieving asthma symptoms. However, they do not specifically address airway inflammation, which is a crucial aspect of asthma management.

D. **Option D (Corticosteroids aren't mentioned):** Corticosteroids are medications that suppress the immune system, reducing inflammation and immune responses. They are crucial in the management of asthma as they address the inflammation aspect of the disease.

**Why the Correct Answer is C:**

The correct answer is option C ("Option C (Bronchodilators aren't mentioned)") because asthma is a complex disorder involving airway inflammation and bronchoconstriction. While anticholinergics are bronchodilators that help relieve asthma symptoms by relaxing bronchial smooth muscles, they do not specifically address the inflammation component of asthma, which is essential for effective management.

**Core Concept:** Asthma is a chronic respiratory condition characterized by bronchoconstriction, airway inflammation, and mucus production. The primary aim of asthma treatment is to alleviate symptoms and prevent exacerbations, while also addressing the underlying inflammation.

**Explanation of Asthma Pathophysiology:**

The pathophysiology of asthma involves bronchial smooth muscle contraction, airway inflammation, and mucus production. Bronchoconstriction leads to airway narrowing, reducing airflow and causing symptoms like shortness of breath, wheezing, chest tightness, and coughing. Inflammation contributes to airway hyperresponsiveness and remodeling, worsening the condition. Mucus production thickens and hypersecretes, obstructing the airways further.

**Why Anticholinergics are Bronchodilators:**

Anticholinergics, acting as muscarinic antagonists, are bronchodilators that help relax bronchial smooth muscles, leading to improved airflow and symptom relief. By blocking